ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$INBX:NASDAQ · Inhibrx Biosciences Inc - US

Biologic therapeutics biotech

Sector: health

Conviction from: NASDAQ

52-week range: 57.30155.29

2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 68 — mean of 2 scored holder(s) · buyers (new/add) avg 61. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy8,542$854,8830.0%
Steve Cohen / Point7275Trimmed -36%16,673$1,668,6340.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-10-14Lappe Markdirector+officer10,040$848,977Form 4
2026-09-28Lappe Markdirector+officer10,000$998,784Form 4
2026-09-23Kayyem Jon Faizdirector5,000$500,000Form 4
2026-09-17Kayyem Jon Faizdirector5,000$500,000Form 4
2026-09-08FORSYTH DOUGLAS (cluster of 3)director2,500$286,617Form 4
2026-09-08Kayyem Jon Faiz (cluster of 3)director5,000$567,580Form 4
2026-09-08Lappe Mark (cluster of 3)director+officer25,000$2,645,399Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.